The strong increase in ISGs in non-pneumonic compared to pneumonic COVID-19 patients was reflected by an elevated ISG-score across CD4+ T cells, NK cells and was particularly prominent in monocytes (Fig. 3c). This evidence concerns the gene CD4 and COVID-19.